• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session

    6/3/24 8:13:57 AM ET
    $AVXL
    $BWLP
    $CMPS
    $GSK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Transportation Services
    Consumer Discretionary
    Get the next $AVXL alert in real time by email

    U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 0.5% on Monday.

    Shares of GSK plc (NYSE:GSK) fell sharply in today's pre-market trading after the company said it will appeal a ruling made by the Delaware State Court regarding its ongoing ranitidine litigation.

    GSK shares tumbled 9.2% to $40.66 in pre-market trading.

    Here are some big stocks recording losses in today's pre-market trading session.

    • The Boston Beer Company, Inc. (NYSE:SAM) shares fell 9.5% to $ 284.04 in pre-market trading. Boston Beer shares jumped around 22% on Friday following a report suggesting the company is in talks to sell itself to Suntory. Boston Beer later issued a statement on the company sale speculation. "We are fully focused on our business as an independent company and our return to growth," the company said.
    • Anavex Life Sciences Corp (NASDAQ:AVXL) shares declined 8.9% to $3.70 in pre-market trading. Anavex Life Sciences recently announced expansion of leadership team.
    • Sezzle Inc (NASDAQ:SEZL) shares declined 5.6% to $75.66 in pre-market trading.
    • Cassava Sciences, Inc. (NASDAQ:SAVA) shares fell 5.5% to $20.83 in pre-market trading.
    • OneWater Marine Inc. (NASDAQ:ONEW) shares fell 5.2% to $24.50 in pre-market trading. Bloomberg reported Sunday that OneWater is in talks to buy MarineMax for $40 per share. OneWater Marine responded to market reports, saying, “As a matter of policy, we do not comment on market rumors or speculation.”
    • Murano Global Investments Plc (NASDAQ:MRNO) shares declined 4.4% to $10.28 in pre-market trading after falling around 9% on Friday.
    • Compass Pathways PLC (NASDAQ:CMPS) shares fell 3.7% to $7.10 in pre-market trading.
    • BW LPG Limited (NYSE:BWLP) shares slipped 3.4% to $21.19 in pre-market trading. The company, last week, reported results for its first quarter and declared a quarterly cash dividend of $1.00/share.

    Now Read This: Science Applications International, Autodesk And 3 Stocks To Watch Heading Into Monday

    Don't forget to check out our premarket coverage here

    Get the next $AVXL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVXL
    $BWLP
    $CMPS
    $GSK

    CompanyDatePrice TargetRatingAnalyst
    Sezzle Inc.
    $SEZL
    2/12/2026$85.00Buy
    Needham
    GSK plc
    $GSK
    1/27/2026Neutral
    Citigroup
    GSK plc
    $GSK
    1/6/2026Equal Weight → Underweight
    Barclays
    COMPASS Pathways Plc
    $CMPS
    12/10/2025$15.00Perform → Outperform
    Oppenheimer
    BW LPG Limited
    $BWLP
    12/3/2025Neutral → Buy
    Clarksons Platou
    GSK plc
    $GSK
    11/25/2025Underperform → Neutral
    BofA Securities
    Boston Beer Company Inc.
    $SAM
    10/6/2025$235.00Buy → Neutral
    Citigroup
    Sezzle Inc.
    $SEZL
    9/11/2025$82.00Hold
    TD Cowen
    More analyst ratings

    $AVXL
    $BWLP
    $CMPS
    $GSK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Leo Pui Ying

    3 - BW LPG Ltd (0001649313) (Issuer)

    3/17/26 12:07:22 PM ET
    $BWLP
    Transportation Services
    Consumer Discretionary

    SEC Form 3 filed by new insider Banerjee Prodyut

    3 - BW LPG Ltd (0001649313) (Issuer)

    3/17/26 12:06:43 PM ET
    $BWLP
    Transportation Services
    Consumer Discretionary

    SEC Form 3 filed by new insider Knutsen Knut-Helge

    3 - BW LPG Ltd (0001649313) (Issuer)

    3/17/26 12:05:51 PM ET
    $BWLP
    Transportation Services
    Consumer Discretionary

    $AVXL
    $BWLP
    $CMPS
    $GSK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham initiated coverage on Sezzle with a new price target

    Needham initiated coverage of Sezzle with a rating of Buy and set a new price target of $85.00

    2/12/26 7:13:35 AM ET
    $SEZL
    Finance: Consumer Services
    Finance

    Citigroup initiated coverage on GlaxoSmithKline

    Citigroup initiated coverage of GlaxoSmithKline with a rating of Neutral

    1/27/26 8:46:26 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GlaxoSmithKline downgraded by Barclays

    Barclays downgraded GlaxoSmithKline from Equal Weight to Underweight

    1/6/26 11:51:57 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVXL
    $BWLP
    $CMPS
    $GSK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Truly Hard Seltzer is Giving One Lucky Friend Group their Own Reality Show this Spring Break – and Taps Breakout Reality Star JaNa Craig to Help with Casting

    BOSTON, March 18, 2026 (GLOBE NEWSWIRE) -- Every friend group thinks they've got what it takes to star in a hit reality TV show. And this spring break, Truly Hard Seltzer is here to make their dreams come truly. Truly is launching Truly Unscripted: Spring Break, an open casting call giving one real friend group the chance to star in their own reality TV miniseries, complete with an all-expenses-paid weekend getaway where a full production crew will document their every move. Beginning today, friend groups nationwide can submit their crew and their case for why they deserve the cameras – and of course, why they bring the drama. The winning group will be whisked away to an epic be

    3/18/26 9:01:00 AM ET
    $SAM
    Beverages (Production/Distribution)
    Consumer Staples

    Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson's Disease at AD/PD 2026 Conference

    New data show that blarcamesine completely rescued impaired motor function Biomarker of nerve fiber density of dopaminergic nerve cells indicating fiber regrowth in striatum with blarcamesine New Parkinson's model of combined alpha-synuclein pathology and noradrenergic degeneration NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced

    3/17/26 7:30:00 AM ET
    $AVXL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    GSK's RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18–49 Years at Increased Risk

    In the US, an estimated 21 million adults under 50 have at least one risk factor for severe RSV infection1* GSK plc (LSE/NYSE:GSK) today announced that the US Food and Drug Administration (FDA) has expanded the approved age indication of AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) to adults aged 18 to 49 years at increased risk for lower respiratory tract disease (LRTD) caused by RSV. AREXVY was previously approved in the US for the prevention of RSV-related LRTD in adults aged 60 and older, and adults aged 50–59 at increased risk for LRTD caused by RSV. This vaccine is not for use in pregnant individuals. Sanjay Gurunathan, GSK Head of Vaccines and Infectious Diseases Re

    3/13/26 11:44:00 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVXL
    $BWLP
    $CMPS
    $GSK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chairman Singleton Philip Austin Jr. bought $307,501 worth of Class A common stock par value $0.01 (24,353 units at $12.63) (SEC Form 4)

    4 - OneWater Marine Inc. (0001772921) (Issuer)

    2/13/26 5:37:49 PM ET
    $ONEW
    Auto & Home Supply Stores
    Consumer Discretionary

    Executive Chairman Singleton Philip Austin Jr. bought $495,263 worth of Class A common stock par value $0.01 (43,179 units at $11.47) (SEC Form 4)

    4 - OneWater Marine Inc. (0001772921) (Issuer)

    11/25/25 4:18:07 PM ET
    $ONEW
    Auto & Home Supply Stores
    Consumer Discretionary

    Director Anderson Robert Eugene Jr bought $24,940 worth of shares (8,600 units at $2.90) (SEC Form 4)

    4 - CASSAVA SCIENCES INC (0001069530) (Issuer)

    11/25/25 4:06:25 PM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVXL
    $BWLP
    $CMPS
    $GSK
    SEC Filings

    View All

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    3/19/26 10:01:19 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    3/19/26 7:17:12 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    3/18/26 12:50:59 PM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVXL
    $BWLP
    $CMPS
    $GSK
    Leadership Updates

    Live Leadership Updates

    View All

    Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors

    NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced the appointment of Dr. Axel Paeger, MD, MBA, MBI to its Board of Directors. "We are delighted to welcome Dr. Paeger to our Board of Directors at Anavex," said Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex. "Dr. Paeger brings three decades of strong leade

    2/23/26 7:30:00 AM ET
    $AVXL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Sezzle Announces Chief Financial Officer Transition

    Minneapolis, MN, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Sezzle, a purpose-driven digital payment platform, today announced the appointment of Lee Brading as Chief Financial Officer ("CFO"), effective February 1, 2026. Brading will succeed Karen Hartje, who served as CFO and principal financial officer under a Consulting Agreement since November 1, 2025, following her announcement of retirement after nearly eight years as CFO of Sezzle. Hartje will remain engaged as a consultant to ensure an orderly transition.  "Karen has been instrumental in Sezzle's evolution from a private startup to a publicly traded, profitable fintech company," said Char

    1/29/26 4:14:17 PM ET
    $SEZL
    Finance: Consumer Services
    Finance

    Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology

    NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced the appointment of Wolfgang Liedtke, MD PhD, as Senior Vice President, Global Head of Neurology. Dr. Liedtke is a board-certified neurologist, who brings more than 25 years of extensive experience in developing and delivering innovative medicines in a broad range of CNS diseases, inclu

    1/8/26 7:30:00 AM ET
    $AVXL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AVXL
    $BWLP
    $CMPS
    $GSK
    Financials

    Live finance-specific insights

    View All

    BW LPG Limited – Ex Dividend US$0.57 on the Oslo Stock Exchange Today

    With reference to the press release dated 3 March 2026 by BW LPG Limited ("BW LPG" or the "Company", OSE ticker code: "BWLPG.OL", NYSE ticker code "BWLP") on key information relating to the cash dividend for Q4 2025, the shares of the Company will be traded ex-dividend on the Oslo Stock Exchange from today and from 13 March 2026 on the New York Stock Exchange. About BW LPG BW LPG is the world's leading owner and operator of LPG vessels, with a fleet of about 50 Very Large Gas Carriers (VLGCs), including 22 vessels powered by LPG dual-fuel propulsion technology. Building on over five decades of LPG shipping experience, the company is strengthened by an in-house LPG trading division and t

    3/12/26 2:02:00 AM ET
    $BWLP
    Transportation Services
    Consumer Discretionary

    BW LPG Limited – Key information relating to the cash dividend for Q4 2025

    BW LPG Limited ("BW LPG" or the "Company", OSE ticker code: "BWLPG.OL", NYSE ticker code "BWLP") provides the following key information relating to the Company's cash dividend for Q4 2025: The Board has approved a dividend of US$0.57 per share on 2 March 2026. For shares registered with Euronext VPS, dividend per share is NOK 5.4297. Record date: 13 March 2026 Shares registered with Euronext VPS - Oslo Stock Exchange ========================================================== Last trading day including the right to receive this dividend: 11 March 2026 Ex-date: 12 March 2026 Dividend payment date: On or about 23 March 2026 Shares registered with Depository Trust Company – New York Sto

    3/3/26 1:03:00 AM ET
    $BWLP
    Transportation Services
    Consumer Discretionary

    BW LPG Limited – Financial Results for Q4 2025

    BW LPG Limited: Highlights Q4 2025 Q4 2025 profit Q4 2025 profit attributable to equity holders of the Company ended at US$104 million, representing an earnings per share of US$0.69, a result of solid shipping performance and continued positive results from Product Services. Q4 TCE performance TCE income – Shipping Q4 2025 concluded at US$50,300 per available day, above our guidance of US$47,000 per day, and US$48,100 per calendar day. The earnings were well supported by the Company's time charter coverage of 44% of available days at US$ 48,100 per day. Q1 2026 guidance Fixed 94% of available fleet days at an average rate of ~US$54,000 per day. Cash dividend declared

    3/3/26 1:02:00 AM ET
    $BWLP
    Transportation Services
    Consumer Discretionary

    $AVXL
    $BWLP
    $CMPS
    $GSK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by COMPASS Pathways Plc

    SC 13G/A - COMPASS Pathways plc (0001816590) (Subject)

    11/14/24 4:35:16 PM ET
    $CMPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by COMPASS Pathways Plc

    SC 13G/A - COMPASS Pathways plc (0001816590) (Subject)

    11/14/24 4:20:24 PM ET
    $CMPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Boston Beer Company Inc.

    SC 13G/A - BOSTON BEER CO INC (0000949870) (Subject)

    11/14/24 1:28:28 PM ET
    $SAM
    Beverages (Production/Distribution)
    Consumer Staples